| 1 |
Micronization of copper indomethacin using gas antisolvent processes
Warwick B, Dehghani F, Foster NR, Biffin JR, Regtop HL
Industrial & Engineering Chemistry Research, 41(8), 1993, 2002 |
| 2 |
Synthesis, purification, and micronization of pharmaceuticals using the gas antisolvent technique
Warwick B, Dehghani F, Foster NR, Biffin JR, Regtop HL
Industrial & Engineering Chemistry Research, 39(12), 4571, 2000 |
| 3 |
Syntheses and characterization of anti-inflammatory dinuclear and mononuclear zinc indomethacin complexes. Crystal structures of [Zn-2(indomethacin)(4)(L)(2)] (L = N,N-dimethylacetamide, pyridine, 1-methyl-2-pyrrolidinone) and [Zn(indomethacin)(2)(L-1)(2)] (L-1 = Ethanol, methanol)
Zhou QD, Hambley TW, Kennedy BJ, Lay PA, Turner P, Warwick B, Biffin JR, Regtop HL
Inorganic Chemistry, 39(17), 3742, 2000 |
| 4 |
Anti-inflammatory dinuclear copper(II) complexes with indomethacin. Synthesis, magnetism and EPR spectroscopy. Crystal structure of the N,N-dimethylformamide adduct
Weder JE, Hambley TW, Kennedy BJ, Lay PA, MacLachlan D, Bramley R, Delfs CD, Murray KS, Moubaraki B, Warwick B, Biffin JR, Regtop HL
Inorganic Chemistry, 38(8), 1736, 1999 |
